Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford, UK.
Departmens of Health Promotion and Human Behavior and of Clinical Epidemiology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Bipolar Disord. 2021 Aug;23(5):445-453. doi: 10.1111/bdi.13070. Epub 2021 Mar 16.
Circadian rhythm disruption is commonly reported in patients with bipolar disorder. Lithium has been suggested to have effects on the circadian clock, the biological basis of the circadian rhythm. The objective of the current review was to review systematically the existing studies on the effect of lithium on circadian rhythm in patients with bipolar disorder.
We systematically searched the scientific literature up to September 2020 for experimental or observational studies which measured circadian rhythm in bipolar patients taking lithium (in comparison with placebo or other active treatments) and carried out a meta-analysis. Circadian rest-activity was our primary outcome, but we also collected data about sleep quality and chronotype (Morningness-Eveningness). The protocol was registered in PROSPERO (CRD42018109790).
Four observational studies (n = 668) and one experimental study (n = 29) were included. Results from the meta-analysis suggest a potential association between lithium and shifts towards morningness (standardized mean difference [SMD]: 0.42, 95% confidence interval [CI]: -0.05 to 0.90). One cohort study with 21 days of follow-up found that patients treated with lithium had significantly larger amplitude (0.68, 0.01 to 1.36) when compared to anticonvulsants.
This review highlights the insufficient evidence to inform us about the effect of lithium on circadian rhythm. However, we found that chronotype can be a potential target for further exploration of biomarkers or biosignatures of lithium treatment in patients with bipolar disorder. Further studies with prospective and longitudinal study design, adopting actigraphy to monitor daily circadian rest-activity changes are needed.
昼夜节律紊乱在双相情感障碍患者中较为常见。有研究表明,锂对生物钟(昼夜节律的生物学基础)有影响。本综述旨在系统性回顾锂对双相情感障碍患者昼夜节律影响的现有研究。
我们系统检索了截至 2020 年 9 月的科学文献,以寻找评估锂治疗(与安慰剂或其他活性治疗相比)对双相情感障碍患者昼夜节律影响的实验或观察性研究,并进行了荟萃分析。昼夜节律休息-活动是我们的主要结局,但我们还收集了关于睡眠质量和昼夜类型(早睡型/晚睡型)的数据。该方案已在 PROSPERO(CRD42018109790)中注册。
共纳入四项观察性研究(n=668)和一项实验性研究(n=29)。荟萃分析结果表明,锂与向早睡型转变之间可能存在关联(标准化均数差[SMD]:0.42,95%置信区间[CI]:-0.05 至 0.90)。一项为期 21 天的随访队列研究发现,与抗惊厥药相比,锂治疗的患者昼夜节律振幅显著增大(0.68,0.01 至 1.36)。
本综述强调了目前关于锂对昼夜节律影响的证据不足。然而,我们发现昼夜类型可能是进一步探索双相情感障碍患者锂治疗的生物标志物或生物特征的潜在靶点。需要进一步开展前瞻性和纵向研究设计,采用活动记录仪监测日常昼夜节律休息-活动变化的研究。